A detailed history of Oregon Public Employees Retirement Fund transactions in Abb Vie Inc. stock. As of the latest transaction made, Oregon Public Employees Retirement Fund holds 151,125 shares of ABBV stock, worth $27.8 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
151,125
Previous 151,665 0.36%
Holding current value
$27.8 Million
Previous $26 Million 14.73%
% of portfolio
0.59%
Previous 0.54%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$163.84 - $199.33 $88,473 - $107,638
-540 Reduced 0.36%
151,125 $29.8 Million
Q2 2024

Aug 01, 2024

BUY
$154.79 - $180.76 $119,343 - $139,365
771 Added 0.51%
151,665 $26 Million
Q1 2024

May 02, 2024

SELL
$159.82 - $182.1 $6.76 Million - $7.7 Million
-42,294 Reduced 21.89%
150,894 $27.5 Million
Q4 2023

Feb 12, 2024

SELL
$137.6 - $154.97 $4.67 Million - $5.25 Million
-33,907 Reduced 14.93%
193,188 $29.9 Million
Q3 2023

Oct 26, 2023

SELL
$133.59 - $154.65 $5.62 Million - $6.51 Million
-42,104 Reduced 15.64%
227,095 $33.9 Million
Q2 2023

Jul 26, 2023

SELL
$132.51 - $164.9 $32 Million - $39.8 Million
-241,454 Reduced 47.28%
269,199 $36.3 Million
Q1 2023

May 04, 2023

SELL
$144.61 - $166.54 $966,573 - $1.11 Million
-6,684 Reduced 1.29%
510,653 $81.4 Million
Q4 2022

Jan 26, 2023

SELL
$138.31 - $165.87 $7.07 Million - $8.48 Million
-51,101 Reduced 8.99%
517,337 $0
Q3 2022

Nov 01, 2022

SELL
$134.21 - $153.93 $2.53 Million - $2.9 Million
-18,872 Reduced 3.21%
568,438 $76.3 Million
Q2 2022

Jul 25, 2022

BUY
$137.62 - $174.96 $26.1 Million - $33.2 Million
189,607 Added 47.68%
587,310 $90 Million
Q1 2022

Apr 21, 2022

SELL
$131.98 - $163.75 $4.06 Million - $5.03 Million
-30,737 Reduced 7.17%
397,703 $64.5 Million
Q4 2021

Feb 01, 2022

SELL
$107.43 - $135.93 $3.89 Million - $4.92 Million
-36,224 Reduced 7.8%
428,440 $58 Million
Q3 2021

Oct 19, 2021

BUY
$106.4 - $120.78 $1.49 Million - $1.69 Million
14,018 Added 3.11%
464,664 $50.1 Million
Q2 2021

Jul 23, 2021

SELL
$105.21 - $117.21 $31.7 Million - $35.3 Million
-300,986 Reduced 40.04%
450,646 $50.8 Million
Q1 2021

Apr 20, 2021

BUY
$102.3 - $112.62 $1.2 Million - $1.32 Million
11,732 Added 1.59%
751,632 $81.3 Million
Q4 2020

Feb 09, 2021

BUY
$80.49 - $108.67 $20.6 Million - $27.9 Million
256,298 Added 53.0%
739,900 $79.3 Million
Q3 2020

Nov 03, 2020

SELL
$85.91 - $100.83 $2.71 Million - $3.18 Million
-31,491 Reduced 6.11%
483,602 $42.4 Million
Q2 2020

Jul 21, 2020

SELL
$73.37 - $98.18 $479,766 - $641,999
-6,539 Reduced 1.25%
515,093 $50.6 Million
Q1 2020

Apr 20, 2020

BUY
$64.5 - $97.79 $24.5 Million - $37.2 Million
380,202 Added 268.83%
521,632 $39.7 Million
Q4 2019

Feb 05, 2020

SELL
$72.13 - $90.25 $594,134 - $743,389
-8,237 Reduced 5.5%
141,430 $12.5 Million
Q3 2019

Nov 07, 2019

SELL
$62.98 - $75.72 $551,641 - $663,231
-8,759 Reduced 5.53%
149,667 $11.3 Million
Q2 2019

Jul 16, 2019

BUY
$65.7 - $83.98 $60,312 - $77,093
918 Added 0.58%
158,426 $11.5 Million
Q1 2019

May 07, 2019

SELL
$77.14 - $90.79 $564,741 - $664,673
-7,321 Reduced 4.44%
157,508 $12.7 Million
Q4 2018

Feb 07, 2019

SELL
$77.85 - $96.01 $1.17 Billion - $1.44 Billion
-15,030,757 Reduced 98.92%
164,829 $15.2 Million
Q4 2018

Feb 05, 2019

BUY
$77.85 - $96.01 $1.16 Billion - $1.43 Billion
14,856,786 Added 4385.12%
15,195,586 $165,000
Q3 2018

Oct 30, 2018

SELL
$88.91 - $98.84 $1.18 Million - $1.31 Million
-13,284 Reduced 3.77%
338,800 $32 Million
Q2 2018

Aug 13, 2018

SELL
$89.78 - $106.23 $4.74 Million - $5.6 Million
-52,744 Reduced 13.03%
352,084 $32.6 Million
Q1 2018

Apr 12, 2018

BUY
$92.01 - $123.21 $259,744 - $347,821
2,823 Added 0.7%
404,828 $38.3 Million
Q4 2017

Jan 11, 2018

BUY
$89.56 - $98.21 $20.7 Million - $22.7 Million
231,520 Added 135.8%
402,005 $0
Q3 2017

Nov 02, 2017

BUY
$69.85 - $89.22 $11.9 Million - $15.2 Million
170,485
170,485 $15.1 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $325B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Oregon Public Employees Retirement Fund Portfolio

Follow Oregon Public Employees Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oregon Public Employees Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Oregon Public Employees Retirement Fund with notifications on news.